Introduction to Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line
The Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of the human TNF receptor superfamily member CD269, also known as TNFRSF17 or B-cell maturation antigen (BCMA). This stable cell line is derived from HEK293T cells, which are commonly used in biotechnology and pharmaceutical research due to their high transfection efficiency and ability to express a wide range of proteins.
Structure of Human CD269/TNFRSF17/BCMA
The CD269 protein is a type III transmembrane protein that belongs to the TNF receptor superfamily. It is predominantly expressed on the surface of B cells and plays a critical role in B cell maturation and survival. The human CD269 protein consists of 184 amino acids and contains a single extracellular cysteine-rich domain, a transmembrane domain, and a cytoplasmic tail. The extracellular domain of CD269 is responsible for binding to its ligands, which include the cytokines BAFF and APRIL.
Activity of Human CD269/TNFRSF17/BCMA
The main function of CD269 is to promote B cell survival and differentiation. This is achieved through the activation of the NF-κB signaling pathway, which is initiated upon ligand binding to CD269. This leads to the upregulation of anti-apoptotic genes and the downregulation of pro-apoptotic genes, ultimately promoting B cell survival. In addition, CD269 has been shown to play a role in regulating antibody production and class switching in B cells.
CD269 has also been identified as a therapeutic target in various B cell-related diseases, such as multiple myeloma and B cell lymphomas. In these diseases, CD269 is overexpressed and promotes the survival and proliferation of malignant B cells. Therefore, targeting CD269 with specific inhibitors or antibodies has shown promising results in preclinical studies and is currently being investigated as a potential treatment option.
Application of Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line
The Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line is a valuable tool for studying the structure and function of CD269. It can be used to investigate the binding affinity and specificity of CD269 to its ligands, as well as the downstream signaling pathways activated upon ligand binding. Additionally, this stable cell line can be used to screen for potential CD269 inhibitors or antibodies for therapeutic purposes.
One of the main advantages of using this stable cell line is its ability to express high levels of functional CD269 protein, which is essential for studying its activity and interactions with other molecules. Furthermore, the HEK293T cell background allows for easy transfection and manipulation of the stable cell line, making it a versatile tool for various research applications.
Flow Cytometry Analysis of Human CD269/TNFRSF17/BCMA Expression
Flow cytometry is a powerful technique for analyzing the expression of cell surface proteins, such as CD269. Using fluorescently labeled antibodies specific to CD269, the level of expression of this protein can be quantified in different cell populations. The Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line can be used as a positive control in flow cytometry experiments, providing a reliable and consistent source of CD269 expression.
Conclusion
The Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of CD269, a key player in B cell biology and a potential therapeutic target in B cell-related diseases.
There are no reviews yet.